Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin.
循环中的白细胞介素-22 是新诊断的 2 型糖尿病的生物标志物，并且与西格列汀的降血糖作用相关
期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S509866
Sun Peiye, Xiao Yuxi, Dong Yuan, Feng Yixiang, Zheng Hongting, Liao Xiaoyu
